Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate

J Biol Chem. 1994 Sep 23;269(38):23817-23.

Abstract

In response to Ca2+ entry, several prominent brain nerve terminal phosphoproteins undergo dephosphorylation, but the relation between dephosphorylation and neurotransmitter release is unknown. Using the immunosuppressants cyclosporin A (CsA) and L-683,590 (FK-520) to inhibit specifically the Ca2+/calmodulin-dependent protein phosphatase calcineurin, we demonstrate here that Ca(2+)-dependent dephosphorylation in isolated rat brain nerve terminals (synaptosomes) is mediated by calcineurin. Pretreatment with micromolar CsA resulted in a 76-95% inhibition of stimulation-induced decreases in 32P-labeled dynamin (previously referred to as dephosphin), a phosphoprotein of M(r) = 145,000 (145-kDa protein), and a phosphoprotein of M(r) = 170,000 (170-kDa protein). Pretreatment with FK-520 also inhibited Ca(2+)-dependent dephosphorylation. Using hypotonic lysates of 32P-labeled synaptosomes, the addition of Ca2+ plus calmodulin, but not either agent alone, induced dynamin dephosphorylation. CsA and FK-520 had little to no effect on the release of glutamate induced by either K(+)-depolarization or the Ca2+ ionophore ionomycin. In contrast, calcineurin inhibition led to a substantial enhancement of glutamate release evoked by the K(+)-channel blocker 4-aminopyridine, an agent whose action most closely mimics physiological stimulation. Calcineurin inhibition had no effect on stimulation-induced changes in synaptosomal Ca2+ levels. Based on our findings, we hypothesize that Ca(2+)-dependent protein dephosphorylation resulting from calcineurin activation during physiological stimulation limits neurotransmitter release from brain nerve terminals, perhaps being dependent upon cyclic repolarization of the membrane during stimulation.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 4-Aminopyridine / pharmacology
  • Amino Acid Sequence
  • Animals
  • Calcineurin
  • Calcium / metabolism
  • Calmodulin-Binding Proteins / pharmacology*
  • Cell-Free System
  • Cerebral Cortex / metabolism
  • Cyclosporine / pharmacology
  • Dynamins
  • Ethers, Cyclic / pharmacology
  • GTP Phosphohydrolases / metabolism
  • Glutamates / metabolism*
  • Membrane Potentials
  • Molecular Sequence Data
  • Nerve Endings / metabolism*
  • Nerve Tissue Proteins / metabolism
  • Okadaic Acid
  • Phosphoprotein Phosphatases / metabolism
  • Phosphoprotein Phosphatases / pharmacology*
  • Phosphoproteins / metabolism*
  • Potassium / pharmacology
  • Potassium Channels / drug effects
  • Rats
  • Synaptic Transmission / drug effects
  • Synaptosomes / metabolism
  • Tacrolimus / analogs & derivatives
  • Tacrolimus / antagonists & inhibitors

Substances

  • Calmodulin-Binding Proteins
  • Ethers, Cyclic
  • Glutamates
  • Nerve Tissue Proteins
  • Phosphoproteins
  • Potassium Channels
  • Okadaic Acid
  • Cyclosporine
  • immunomycin
  • 4-Aminopyridine
  • Calcineurin
  • Phosphoprotein Phosphatases
  • GTP Phosphohydrolases
  • Dynamins
  • Potassium
  • Calcium
  • Tacrolimus